News and
Events
- May 9, 2023
Curesponse Presents Positive Preliminary Clinical Results from a Multi-Center UK Study at AACR
- Mar 30, 2023
Curesponse discusses its cancer prediction cResponse™ test with Ynet (in hebrew)
- Feb 23, 2023
Curesponse Announces Clalit Health Services, Largest Israeli HMO, to Provide Commercial Coverage for the cResponse™ test
- Dec 21, 2022
Curesponse shows applicability with next generation immuno-oncology drugs
- May 15, 2022
Curesponse to exhibit at ASCO, 2022
- Apr 28, 2022
Curesponse to present at BIOMED Israel, 2022
- Feb 28, 2022
Curesponse publishes new clinical study in Nature Cancer
- Feb 2, 2022
Curesponse and Rafael announce collaboration
- Jan 5, 2022
Curesponse interviewed on Israel Channel 13
- Nov 5, 2021
Curesponse secures additional USD 8 Million funding
Want to know more?